Correction to: “Comments on Injectable Estradiol Use in Transgender and Gender-diverse Individuals in the United States” - Takeaways - MDSpire

Correction to: “Comments on Injectable Estradiol Use in Transgender and Gender-diverse Individuals in the United States”

  • January 7, 2026

  • 0 min

Share

  • 1

    An error was identified in the article discussing injectable estradiol in transgender populations.

  • 2

    The original text inaccurately described testosterone suppression rates in patients using estradiol monotherapy.

  • 3

    The corrected version clarifies that 21.6% of patients achieved testosterone suppression without antiandrogens.

  • 4

    The article emphasizes the need for further investigation into estradiol monotherapy effectiveness.

  • 5

    The correction has been officially published online to ensure accurate information dissemination.

Original Source(s)

Correction to: “Comments on Injectable Estradiol Use in Transgender and Gender-diverse Individuals in the United States”

  • January 7, 2026

Related Content

Machine Learning Prediction Model for Dyslipidemia and Its Association With Atherothrombotic Events in 3 Independent Cohorts From South Korea, Japan, and the United Kingdom: Algorithm Development and Validation Study

Ethics of non-oncological fertility preservation from the perspective of the four principles of bioethics

Combination Therapy Shows Potential in Psoriasis, Obesity

Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.